Genenta Science S.p.A.

GNTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.70

+$0.02 (+3.37%)

Sep 22, 2026, 11:34 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.37%

(1D)

Rating

Updated: Sep 7, 2026

Fundamentals Weak

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $13.4M

1D Range

0.68 0.72

52W Range

0.55 10

Valuation (TTM)

PE -1.33

PB 0.91

EV/EBITDA -0.10

Valuation (NTM)

Forward PE N/A

Forward PEG -0.12

Price Target N/A

Cash Flow

FCF Yield -55.1%

SBC Adj. FCF Yield -62.6%

SBC Impact -13.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 2.7% | -15.5%

FCF 3Y | 5Y -67.9% | -6.1%

Returns

ROA -19.6%

ROE -36.8%

ROIC -21.3%

Financial Health

Net Cash

€10.11M ($11.92M)

Current Ratio 14.16

Interest Coverage -17.01

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon,...

Sector Healthcare

Industry Biotechnology

Employees 9

IPO Date Dec 14, 2021

Website www.genenta.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.